120 related articles for article (PubMed ID: 22972598)
1. Catechins in neuroAIDS.
Mocchetti I
J Neurovirol; 2012 Dec; 18(6):443-4. PubMed ID: 22972598
[No Abstract] [Full Text] [Related]
2. Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway.
Nath S; Bachani M; Harshavardhana D; Steiner JP
J Neurovirol; 2012 Dec; 18(6):445-55. PubMed ID: 22886603
[TBL] [Abstract][Full Text] [Related]
3. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization.
Bachis A; Major EO; Mocchetti I
J Neurosci; 2003 Jul; 23(13):5715-22. PubMed ID: 12843275
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation.
Sui Z; Fan S; Sniderhan L; Reisinger E; Litzburg A; Schifitto G; Gelbard HA; Dewhurst S; Maggirwar SB
J Immunol; 2006 Jul; 177(1):702-11. PubMed ID: 16785569
[TBL] [Abstract][Full Text] [Related]
6. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.
Nath A; Haughey NJ; Jones M; Anderson C; Bell JE; Geiger JD
Ann Neurol; 2000 Feb; 47(2):186-94. PubMed ID: 10665489
[TBL] [Abstract][Full Text] [Related]
7. Catechins containing a galloyl moiety as potential anti-HIV-1 compounds.
Zhao Y; Jiang F; Liu P; Chen W; Yi K
Drug Discov Today; 2012 Jun; 17(11-12):630-5. PubMed ID: 22414543
[TBL] [Abstract][Full Text] [Related]
8. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.
Hermes DJ; Xu C; Poklis JL; Niphakis MJ; Cravatt BF; Mackie K; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
Neuropharmacology; 2018 Oct; 141():55-65. PubMed ID: 30114402
[TBL] [Abstract][Full Text] [Related]
10. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
Teodorof-Diedrich C; Spector SA
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors.
Jiang F; Chen W; Yi K; Wu Z; Si Y; Han W; Zhao Y
Clin Immunol; 2010 Dec; 137(3):347-56. PubMed ID: 20832370
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo.
Nosheny RL; Ahmed F; Yakovlev A; Meyer EM; Ren K; Tessarollo L; Mocchetti I
Eur J Neurosci; 2007 Apr; 25(8):2275-84. PubMed ID: 17445226
[TBL] [Abstract][Full Text] [Related]
13. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor prevents human immunodeficiency virus type 1 protein gp120 neurotoxicity in the rat nigrostriatal system.
Mocchetti I; Nosheny RL; Tanda G; Ren K; Meyer EM
Ann N Y Acad Sci; 2007 Dec; 1122():144-54. PubMed ID: 18077570
[TBL] [Abstract][Full Text] [Related]
15. NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation.
D'Aversa TG; Eugenin EA; Berman JW
J Neurosci Res; 2005 Aug; 81(3):436-46. PubMed ID: 15954144
[TBL] [Abstract][Full Text] [Related]
16. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
17. Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.
Stevens PR; Gawryluk JW; Hui L; Chen X; Geiger JD
Curr HIV Res; 2014; 12(6):378-87. PubMed ID: 25613139
[TBL] [Abstract][Full Text] [Related]
18. Peptides derived from HIV-1 gp120 co-receptor binding domain form amyloid fibrils and enhance HIV-1 infection.
Tan S; Li L; Lu L; Pan C; Lu H; Oksov Y; Tang X; Jiang S; Liu S
FEBS Lett; 2014 May; 588(9):1515-22. PubMed ID: 24657436
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
20. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
